Popularized in films like Limitless, legal smart drugs called Nootropics are becoming more and more prevalent in board rooms and on Wall Street.Keep reading »
Private equity firm Carlyle Group sold its remaining stake in China’s No.3 insurer CPIC in a deal valued at $793 million, exiting the business with its largest dollar profit on an investment.
Cerberus plans to reduce its stake to about 8% by offering shares in the open market, Aozora said, in a deal that would generate ¥158.1 billion ($1.8 billion) based on Monday’s closing price of ¥250 a share on the Tokyo Stock Exchange. That is on top of an estimated ¥100 billion Cerberus made from cashing out some of its stake at a much higher price in 2006, when Aozora’s initial public offering priced shares at ¥570.
As the Journal points out, Cerberus is just the lastest p.e. shop, among the hordes who descended on Japan back when it was showing us what a middle-aged decades-long recession looked like, to quit its Japanese bank habit. Lone Star and J.C. Flowers are still biding their time.